Drug-targeting in combined cancer chemotherapy: Tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion

Cellular Oncology

Volumn 35, Issue 6, 2012, Pages 451-460

  Kretzer, Iara F ^a   Maria, Durvanei A ^b   Maranhão, Raul C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Cancer treatment; Cholesterol; Drug targeting; Emulsions; Low density lipoprotein (LDL) receptors; Nanoparticles

Indexed keywords

CHOLESTEROL; COLLAGEN FIBER; ETOPOSIDE; LIPID EMULSION; PACLITAXEL; ANTINEOPLASTIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NANOPARTICLE;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL DENSITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG SELECTIVITY; DRUG TARGETING; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; MELANOMA B16; MELANOMA CELL; METASTASIS; MOUSE; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOSIS; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG DELIVERY SYSTEM; EXPERIMENTAL MELANOMA; FLOW CYTOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; METHODOLOGY; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHOLESTEROL, LDL; DRUG DELIVERY SYSTEMS; ETOPOSIDE; FAT EMULSIONS, INTRAVENOUS; FEMALE; FLOW CYTOMETRY; INJECTIONS, INTRAPERITONEAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NANOPARTICLES; PACLITAXEL;

EID: 84879241534     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0104-6     Document Type: Article

References (44)

1. D. Liu, N. Zhang, Cancer chemotherapy with lipid-based nanocarriers. Crit. Rev. Ther. Drug Carr. Syst. 27, 371-417 (2010)
2. R.C. Maranhão, B. Garicochea, E.L. Silva, P. Dorlhiac-Llacer, F.J.C. Pileggi, D.A.F. Chamone, Increased plasma removal of microemulsions resembling the lipid phase of low-density lipoproteins (LDL) in patients with acute myeloid leukemia: A possible new strategy for the treatment of the disease. Braz. J. Med. Biol. Res. 25, 1003-1007 (1992)
3. R.C. Maranhão, T.B. Cesar, M.T.B. Pedroso, M.H. Hirata, C.H. Mesquita, Metabolic behavior in rats of a non protein microemulsion resembling LDL. Lipids 28, 691-696 (1993)
4. R.C. Maranhão, B. Garicochea, E.L. Silva, P. Dorlhiac-Llacer, S.M.S. Cadena, I.J.C. Coelho, J.C. Meneguetti, F.J.C. Pileggi, D.A.F. Chamone, Plasma kinetics and biodistribution of a lipid emulsion resembling low density lipoprotein in patients with acute leukemia. Cancer Res. 54, 4660-4666 (1994)
5. R.D. Hirata,M.H. Hirata, C.H. Mesquita, T.B. Cesar, R.C.Maranhão, Effects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in rats. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1437, 53-62 (1999)
6. Y.K. Ho, R.G. Smith, M.S. Brown, J.L. Goldstein, Low-density lipoprotein (LDL) receptor activity in human acute myelogenous cells. Blood 52, 1099-1114 (1978)
7. H. Ginsberg, H.S. Gilbert, J.C. Gibson, N.A. Le, W.V. Brown, Increased low-density-lipoprotein catabolism in myeloproliferative disorders. Ann. Intern. Med. 96, 311-316 (1982)
8. P. Henriksson, S. Ericsson, R. Stege, M. Ericsson, M. Rudling, L. Berglund, B. Angelin, Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet 2, 1178-1180 (1989)
9. S. Vitols, B. Angelin, S. Ericsson, G. Gahrton, G. Juliusson, M. Masquelier, C. Paul, C. Peterson, M. Rudling, K. Soderberg-Reid, V. Tidefelt, Uptake of low-density lipoproteins by human leukemic cells in vivo: Relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc. Nati. Acad. Sci. USA 87, 2598-2602 (1990)
10. Y. Ueyama, Y. Matsuzawa, S. Yamashita, T. Funahashi, N. Sakai, T. Nakamura, M. Kubo, S. Taru, Hypocholesterolaemic factor from gallbladder cancer cells. Lancet 336, 707-709 (1990)
11. S. Vitols, C. Peterson, O. Larsson, P. Holm, B. Aberg, Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. Cancer Res. 52, 6244-6247 (1992)
12. T. Nakagawa, Y. Ueyama, S. Nozaki, S. Yamashita, M. Menju, T. Funahashi, K. Kameda-Takemura, M. Kubo, K. Tokunaga, T. Tanaka, Marked hypocholesterolemia in a case with adrenal adenoma-enhanced catabolism of low density lipoprotein (LDL) via the LDL receptors of tumor cells. J. Clin. Endocrinol. Metab. 80, 92-96 (1995)
13. A. Stranzl, H. Schmidt, R. Winkler, G.M. Kostner, Low-density lipoprotein receptor mRNA in human breast cancer cells: Influence by PKC modulators. Breast Cancer Res. Treat. 42, 195-205 (1997)
14. Y. Chen, M. Hughes-Fulford, Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int. J. Cancer 91, 41-45 (2001)
15. R.C. Maranhão, S.R. Graziani, N. Yamaguchi, R.F. Melo, M.C. Latrilha, D.G. Rodrigues, R.D. Couto, R. Schreiber, A.C. Buzaid, Association of carmustine with a lipid emulsion: In vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother. Pharmacol. 49, 487-498 (2002). doi:10.1007/s00280-002-0437-3
16. V.T. Hungria, M.C. Latrilha, D.G. Rodrigues, S.P. Bydlowski, C.S. Chiattone, R.C. Maranhão, Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemother. Pharmacol. 53, 51-60 (2004). doi:10.1007/s00280-003-0692-y
17. K.V. Pinheiro, V.T. Hungria, E.S. Ficker, C.J. Valduga, C.H. Mesquita, R.C. Maranhão, Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE. Cancer Chemother. Pharmacol. 57, 624-630 (2005). doi:10.1007/s00280-005-0090-8
18. C.J. Antalis, A. Uchida, K.K. Buhman, R.A. Siddiqui, Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification. Clin. Exp. Metastasis 28, 733-741 (2011). doi:10.1007/s10585-011-9405-9
19. L.A. Pires, R. Hegg, E.R. Freitas, E.R. Tavares, C.P. Almeida, E.C. Baracat, R.C. Maranhão, Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer. Braz. J. Med. Biol. Res. 45, 557-564 (2012). doi:10.1590/S0100-879X2012007500068
20. C.H. Azevedo, J.P. Carvalho, C.J. Valduga, R.C. Maranhão, Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma. Gynecol. Oncol. 97, 178-182 (2005). doi:10.1016/j.ygyno.2004.12.015
21. M.L. Dias, J.P. Carvalho, D.G. Rodrigues, S.R. Graziani, R.C. Maranhão, Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers. Cancer Chemother. Pharmacol. 59, 105-111 (2007). doi:10.1007/s00280-006-0252-3
22. L.A. Pires, R. Hegg, C.J. Valduga, S.R. Graziani, D.G. Rodrigues, R.C. Maranhão, Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: Pharmacokinetics, tumor uptake and a pilot clinical study. Cancer Chemother. Pharmacol. 63, 281-287 (2009). doi:10.1007/s00280-008-0738-2
23. R.S. Teixeira, R. Curi, R.C. Maranhão, Effects on Walker 256 tumor of carmustine associated with a cholesterol-rich microemulsion (LDE). J. Pharm. Pharmacol. 56, 909-914 (2004). doi:10.1211/0022357023826
24. C.J. Valduga, D.C. Fernandes, A.C. Lo Prete, C.H.M Azevedo, D.G. Rodrigues, R.C. Maranhão, Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide. J. Pharm. Pharmacol. 55, 1615-1622 (2004). doi:10.1211/0022357022232
25. A.C. Lo Prete, D.A. Maria, D.G. Rodrigues, C.J. Valduga, O.C. Ibanez, R.C. Maranhão, Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterolrich nano-emulsion. J. Pharm. Pharmacol. 58, 801-808 (2006). doi:10.1211/jpp.58.6.0010
26. D.G. Rodrigues, D.A. Maria, D.C. Fernandes, C.J. Valduga, R.D. Couto, O.C. Ibanez, R.C. Maranhão, Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: In vitro and in vivo studies. Cancer Chemother. Pharmacol. 55, 565-576 (2005). doi:10.1007/ s00280-004-0930-y
27. R.S. Teixeira, C.J. Valduga, L.A. Benvenutti, S. Schreier, R.C. Maranhão, Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors. J. Pharm. Pharmacol. 60, 1287-1295 (2008). doi:10.1211/jpp/60.10.0004
28. K.R. Hande, Topoisomerase II inhibitors. Update on Cancer Therapeutics 1, 3-15 (2006). doi:10.1016/j.uct.2006.04.001
29. Q. Yue, X. Liu, D. Guo, Microtubule-Binding Natural Products for Cancer Therapy. Planta Med. 76, 1037-1043 (2010). doi:10.1055/ s-0030-1250073
30. R.I. Geran, N.H. Greenberg, M.M. Macdonald, A.M. Schumacher, B.J. Abbott, Protocols for screening chemical agents and natural products against animal tumors and other biological systems, 3rd edn. (National Institute of Health, Bethesda, 1972), pp. 47-51
31. A.J. Versluis, P.J. van Gell, H. Oppelaar, T.J.C. van Berkel, M.K. Bijsterbosch, Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice. Br. J. Cancer 74, 525-532 (1996)
32. A. Ades, J.P. Carvalho, S.R. Graziani, R.F. Amancio, J.S. Souen, J.A. Pinotti, R.C. Maranhão, Uptake of a cholesterol-rich emulsion by neoplasic ovarian tissues. Gynecol. Oncol. 82, 84-87 (2001). doi:10.1006/gyno.2001.6203
33. L.C. van Kempen, J. Rijntjes, I. Mamor-Cornelissen, S. Vincent-Naulleau, M.J. Gerritsen, D.J. Ruiter, M.C. van Dijk, C. Geffrotin, G.N. van Muijen, Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma. Int. J. Cancer 122, 1019-1029 (2008). doi:10.1002/ ijc.23147
34. K.P. Claffey, L.F. Brown, L.F. del Aguila, K. Tognazzi, K.T. Yeo, E.J. Manseau, H.F. Dvorak, Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56, 172-181 (1996)
35. R. Ophir, G. Moalem, M. Pecht, M. Shashoua, G. Rashid, S. Ben-Efraim, N. Trainin, Y. Burstein, Y. Keisari, THF-gamma 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanoma. J. Immunother. 22, 103-113 (1999)
36. E.A. Perez, Microtubule inhibitors: Differentiating tubulininhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol. Cancer Ther. 8, 2086-2095 (2009). doi:10.1158/1535-7163.MCT-09-0366
37. I. Schonn, J. Hennesen, D.C. Dartsch, Cellular responses to etoposide: Cell death despite cell cycle arrest and repair of DNA damage. Apoptosis 15, 162-172 (2010). doi:10.1007/s10495-009-0440-9
38. F. Wei, Y. Xie, L. Tao, D. Tang, Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation. Cell. Signal. 22, 1783-1789 (2010). doi:10.1016/j.cellsig.2010.07.007
39. H.L. Lin, Y.F. Chang, T.Y. Liu, C.W. Wu, C.W. Chi, Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase. Anticancer. Res. 18, 3443-3449 (1998)
40. K. Torres, S.B. Horwitz, Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res. 58, 3620-3626 (1998)
41. P. Giannakakou, R. Robey, T. Fojo, M.V. Blagosklonny, Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/ G2 arrest instead of mitotic arrest: Molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20, 3806-3813 (2001)
42. P.C. Liao, C.H. Lieu, Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sci. 76, 1623-1639 (2005). doi:10.1016/j.lfs.2004.09.021
43. Z.N. Demidenko, S. Kalurupalle, C. Hanko, C.U. Lim, E. Broude, M.V. Blagosklonny, Mechanism of G1-like arrest by low concentrations of paclitaxel: Next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Oncogene 27, 4402-4410 (2008)
44. B.B. Lundberg, V. Risovic, M. Ramaswamy, K.M. Wasan, A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J. Control. Release 86, 93-100 (2003)